182 related articles for article (PubMed ID: 25994189)
21. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
22.
Abraham AG; Riauka T; Hudson M; Ghosh S; Zebak S; Alba V; Vaihenberg E; Warkentin H; Tankel K; Severin D; Bedard E; Spratlin J; Mulder K; Joseph K
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):177-187. PubMed ID: 36402622
[TBL] [Abstract][Full Text] [Related]
23. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
Kim SJ; Pak K; Chang S
Br J Radiol; 2016; 89(1058):20150673. PubMed ID: 26607643
[TBL] [Abstract][Full Text] [Related]
24. Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.
Cheng NM; Fang YH; Lee LY; Chang JT; Tsan DL; Ng SH; Wang HM; Liao CT; Yang LY; Hsu CH; Yen TC
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):419-28. PubMed ID: 25339524
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
[TBL] [Abstract][Full Text] [Related]
26. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters.
Galavis PE; Hollensen C; Jallow N; Paliwal B; Jeraj R
Acta Oncol; 2010 Oct; 49(7):1012-6. PubMed ID: 20831489
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer.
Grootjans W; Tixier F; van der Vos CS; Vriens D; Le Rest CC; Bussink J; Oyen WJ; de Geus-Oei LF; Visvikis D; Visser EP
J Nucl Med; 2016 Nov; 57(11):1692-1698. PubMed ID: 27283931
[TBL] [Abstract][Full Text] [Related]
28. Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.
Chen YM; Pan XF; Tong LJ; Shi YP; Chen T
Nucl Med Commun; 2011 Nov; 32(11):1005-10. PubMed ID: 21886014
[TBL] [Abstract][Full Text] [Related]
29. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
[TBL] [Abstract][Full Text] [Related]
30. Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
Zegers CM; van Elmpt W; Hoebers FJ; Troost EG; Öllers MC; Mottaghy FM; Lambin P
Acta Oncol; 2015; 54(9):1378-84. PubMed ID: 26213313
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.
Hatt M; Visvikis D; Albarghach NM; Tixier F; Pradier O; Cheze-le Rest C
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1191-202. PubMed ID: 21365252
[TBL] [Abstract][Full Text] [Related]
32. Tumour necrosis as assessed with
Kahle XU; Hovingh M; Noordzij W; Seitz A; Diepstra A; Visser L; van den Berg A; van Meerten T; Huls G; Boellaard R; Kwee TC; Nijland M
Eur Radiol; 2019 Nov; 29(11):6018-6028. PubMed ID: 31028445
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
Chang S; Kim SJ
Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
[TBL] [Abstract][Full Text] [Related]
34. The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).
Palie O; Michel P; Ménard JF; Rousseau C; Rio E; Bridji B; Benyoucef A; Meyer ME; Jalali K; Bardet S; M'vondo CM; Olivier P; Faure G; Itti E; Diana C; Houzard C; Mornex F; Di Fiore F; Vera P
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1345-55. PubMed ID: 23715903
[TBL] [Abstract][Full Text] [Related]
35. Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.
Benz MR; Evilevitch V; Allen-Auerbach MS; Eilber FC; Phelps ME; Czernin J; Weber WA
J Nucl Med; 2008 Jul; 49(7):1038-46. PubMed ID: 18552153
[TBL] [Abstract][Full Text] [Related]
36. Intratumoral heterogeneity in
Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
[TBL] [Abstract][Full Text] [Related]
37. Dual-time point
Park S; Paeng JC; Kang CH; Cheon GJ; Kang KW; Chung JK; Lee DS
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1317-1328. PubMed ID: 29502309
[TBL] [Abstract][Full Text] [Related]
38. Variability and Repeatability of Quantitative Uptake Metrics in
Zhuang M; García DV; Kramer GM; Frings V; Smit EF; Dierckx R; Hoekstra OS; Boellaard R
J Nucl Med; 2019 May; 60(5):600-607. PubMed ID: 30389824
[TBL] [Abstract][Full Text] [Related]
39.
Linder G; Korsavidou-Hult N; Bjerner T; Ahlström H; Hedberg J
Clin Radiol; 2019 Sep; 74(9):718-725. PubMed ID: 31221468
[TBL] [Abstract][Full Text] [Related]
40. Texture analysis of
Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]